February 19, 2026
Headlines

FDA Approves Merck’s Kidney Cancer Drug For Rare Type Of Neuroendocrine Tumors

Sumain Faisal01 mins

Merck’s Welireg wins FDA approval for rare PPGL tumors; Q1 2025 sales reach $137M, marking a 62% year-over-year increase.

read more

Leave a Reply

Your email address will not be published. Required fields are marked *

Related News